These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1513454)

  • 1. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part III. Reliability of a standardized MRI evaluation of Alzheimer's disease.
    Davis PC; Gray L; Albert M; Wilkinson W; Hughes J; Heyman A; Gado M; Kumar AJ; Destian S; Lee C
    Neurology; 1992 Sep; 42(9):1676-80. PubMed ID: 1513454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropathological assessment of Alzheimer's disease: the experience of the Consortium to Establish a Registry for Alzheimer's Disease.
    Mirra SS
    Int Psychogeriatr; 1997; 9 Suppl 1():263-8; discussion 269-72. PubMed ID: 9447447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of the Korean version of the Consortium to Establish a Registry for Alzheimer's Disease Assessment Packet (CERAD-K): clinical and neuropsychological assessment batteries.
    Lee JH; Lee KU; Lee DY; Kim KW; Jhoo JH; Kim JH; Lee KH; Kim SY; Han SH; Woo JI
    J Gerontol B Psychol Sci Soc Sci; 2002 Jan; 57(1):P47-53. PubMed ID: 11773223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sylvian fissure size in schizophrenia measured with the magnetic resonance imaging rating protocol of the Consortium to Establish a Registry for Alzheimer's Disease.
    Schwartz JM; Aylward E; Barta PE; Tune LE; Pearlson GD
    Am J Psychiatry; 1992 Sep; 149(9):1195-8. PubMed ID: 1503132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Behavior Rating Scale for Dementia of the Consortium to Establish a Registry for Alzheimer's Disease. The Behavioral Pathology Committee of the Consortium to Establish a Registry for Alzheimer's Disease.
    Tariot PN; Mack JL; Patterson MB; Edland SD; Weiner MF; Fillenbaum G; Blazina L; Teri L; Rubin E; Mortimer JA
    Am J Psychiatry; 1995 Sep; 152(9):1349-57. PubMed ID: 7653692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amygdala atrophy in Alzheimer's disease. An in vivo magnetic resonance imaging study.
    Cuénod CA; Denys A; Michot JL; Jehenson P; Forette F; Kaplan D; Syrota A; Boller F
    Arch Neurol; 1993 Sep; 50(9):941-5. PubMed ID: 8363448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlating Cognitive Decline with White Matter Lesion and Brain Atrophy Magnetic Resonance Imaging Measurements in Alzheimer's Disease.
    Bilello M; Doshi J; Nabavizadeh SA; Toledo JB; Erus G; Xie SX; Trojanowski JQ; Han X; Davatzikos C
    J Alzheimers Dis; 2015; 48(4):987-94. PubMed ID: 26402108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease.
    Mirra SS; Heyman A; McKeel D; Sumi SM; Crain BJ; Brownlee LM; Vogel FS; Hughes JP; van Belle G; Berg L
    Neurology; 1991 Apr; 41(4):479-86. PubMed ID: 2011243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interlaboratory comparison of neuropathology assessments in Alzheimer's disease: a study of the Consortium to Establish a Registry for Alzheimer's Disease (CERAD).
    Mirra SS; Gearing M; McKeel DW; Crain BJ; Hughes JP; van Belle G; Heyman A
    J Neuropathol Exp Neurol; 1994 May; 53(3):303-15. PubMed ID: 8176413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CERAD experience, Part VIII: Neuroimaging-neuropathology correlates of temporal lobe changes in Alzheimer's disease.
    Davis PC; Gearing M; Gray L; Mirra SS; Morris JC; Edland SD; Lin T; Heyman A
    Neurology; 1995 Jan; 45(1):178-9. PubMed ID: 7824112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interrater reliability of modified visual mrı rating scale assessing atrophy and white matter changes.
    Yilmaz MK; Yalciner ZB; Tepe SM
    Ideggyogy Sz; 2023 Jan; 76(1-2):19-24. PubMed ID: 36892299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A method to improve interrater reliability of visual inspection of brain MRI scans in dementia.
    Victoroff J; Mack WJ; Grafton ST; Schreiber SS; Chui HC
    Neurology; 1994 Dec; 44(12):2267-76. PubMed ID: 7991111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral infarcts in patients with autopsy-proven Alzheimer's disease: CERAD, part XVIII. Consortium to Establish a Registry for Alzheimer's Disease.
    Heyman A; Fillenbaum GG; Welsh-Bohmer KA; Gearing M; Mirra SS; Mohs RC; Peterson BL; Pieper CF
    Neurology; 1998 Jul; 51(1):159-62. PubMed ID: 9674796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease.
    Morris JC; Heyman A; Mohs RC; Hughes JP; van Belle G; Fillenbaum G; Mellits ED; Clark C
    Neurology; 1989 Sep; 39(9):1159-65. PubMed ID: 2771064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consortium to establish a registry for Alzheimer's disease: development, database structure, and selected findings.
    Fillenbaum GG; Beekly D; Edland SD; Hughes JP; Heyman A; van Belle G
    Top Health Inf Manage; 1997 Aug; 18(1):47-58. PubMed ID: 10173753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part VI. Family history assessment: a multicenter study of first-degree relatives of Alzheimer's disease probands and nondemented spouse controls.
    Silverman JM; Raiford K; Edland S; Fillenbaum G; Morris JC; Clark CM; Kukull W; Heyman A
    Neurology; 1994 Jul; 44(7):1253-9. PubMed ID: 8035925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part X. Neuropathology confirmation of the clinical diagnosis of Alzheimer's disease.
    Gearing M; Mirra SS; Hedreen JC; Sumi SM; Hansen LA; Heyman A
    Neurology; 1995 Mar; 45(3 Pt 1):461-6. PubMed ID: 7898697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging.
    Jobst KA; Barnetson LP; Shepstone BJ
    Int Psychogeriatr; 1997; 9 Suppl 1():191-222; discussion 247-52. PubMed ID: 9447442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortical magnetic resonance imaging changes in elderly inpatients with major depression.
    Rabins PV; Pearlson GD; Aylward E; Kumar AJ; Dowell K
    Am J Psychiatry; 1991 May; 148(5):617-20. PubMed ID: 2018163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between gray matter volume in the temporal lobe and depressive symptoms in patients with Alzheimer's disease.
    Son JH; Han DH; Min KJ; Kee BS
    Neurosci Lett; 2013 Aug; 548():15-20. PubMed ID: 23727389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.